Little Green Pharma Reports Record Revenue and Growth
Company Announcements

Little Green Pharma Reports Record Revenue and Growth

Little Green Pharma Ltd. (AU:LGP) has released an update.

Little Green Pharma Ltd. reported a record revenue of $10.2 million for the quarter ended September 2024, marking a 40% increase from the previous quarter, driven by strong growth in the European cannabis markets. The company also achieved a net operating cash inflow, resulting in a cashflow positive quarter, and improved its cash position to $4.8 million. Cost savings from subcontracting Australian operations are expected to further enhance their financial performance.

For further insights into AU:LGP stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App